At a glance: $125M investment expands Amgen's South San Francisco research hub Integrated labs bring medicinal chemistry, biology, protein sciences, automation, and data science together to accelerate discovery Design/Make/Test/Analyze approach helps teams learn faster, optimize molecules with greater precision, and move potential medicines forward for patients [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Attachments

  • Original document
  • Permalink

Disclaimer

Amgen Inc. published this content on May 06, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 06, 2026 at 18:24 UTC.